Know Cancer

forgot password

Obesity Reduction Black Intervention Trial (ORBIT)

Phase 3
30 Years
50 Years
Open (Enrolling)
Breast Cancer, Obesity, Weight Changes

Thank you

Trial Information

Obesity Reduction Black Intervention Trial (ORBIT)



- To estimate the effectiveness of a 24-week diet and physical activity intervention and
a 1-year maintenance intervention designed to produce and maintain weight loss in obese
black women.

- To estimate the effect of these interventions on changes in fasting serum insulin,
glucose, and free IGF-1, IGFBP-1, and IGFBP-2 levels as well as total IGF-1 and IGFBP-3


- To compare changes in dietary consumption of total calories, total fat, fruits,
vegetables, and fiber as well as physical activity in participants undergoing a
weight-loss intervention vs a control intervention.

- To compare changes in knowledge, attitudes, self-efficacy, and social support related
to diet, physical activity, and weight loss in participants undergoing a weight-loss
intervention vs a control intervention.

- Assess the efficacy of a weight-loss intervention mechanism and the association between
weight loss and weight loss maintenance with potential biologic mediators of breast
cancer risk.

OUTLINE: Participants are randomized to 1 of 2 intervention arms.

- Arm I (weight-loss intervention): Participants undergo a combined weight-loss
intervention (diet and physical activity) over 24 weeks comprising individualized
sessions with an interventionist once monthly and group sessions twice weekly. During
the group sessions, participants receive information about diet, physical activity, and
weight loss and take part in exercise classes. Participants receive handouts,
food-measuring tools, and pedometers. Participants also discuss goal setting and
problem solving. During the individualized sessions, participants undergo motivational
interviewing (MI) to assess their individual needs and to motivate them to make or
sustain behavioral changes.

Beginning 1 month after completion of the combined weight-loss intervention, participants
undergo a weight-loss maintenance intervention over 12 months. Participants continue their
exercise classes twice weekly and receive a copy of the aerobic exercise class videotape for
use at home. Prior to each exercise session, participants may share their weight-loss
experiences (e.g., successes, struggles) or a motivational or informational story, article,
or prayer with other group members. Participants also receive weekly newsletters that
include information presented in the original weight-loss intervention, opportunities in the
community for physical activity (e.g., ice skating, swimming, or local walks), and further
advice on maintaining weight loss. Participants undergo 4 MI sessions over the telephone
that address diet, physical activity, and weight-loss maintenance strategies. The MI
sessions also provide an opportunity for individualized problem solving.

- Arm II (control intervention): Participants undergo a control intervention over 24
weeks comprising weekly newsletters on general health topics, such as first aid,
smoking cessation, cancer screening, and disease prevention, and monthly general health
classes that demonstrate information conveyed in the newsletter (e.g., first-aid

After completion of the control intervention, participants undergo a control maintenance
intervention over 12 months comprising a monthly newsletter on general health topics. After
completion of the maintenance intervention, participants undergo 10 intervention sessions
and receive the same study-related materials (handouts, food-measuring tools, and
pedometers) as in arm I.

Blood samples are collected at baseline, 24 weeks, and 18 months for laboratory biomarker
studies. Samples are analyzed for insulin levels by radioimmunoassay, glucose
concentrations, and total and free IGF-1, IGFBP-1, IGFBP-2, and IGFBP-3 by enzyme-linked

Participants complete questionnaires at baseline, 24 weeks, and 18 months to assess diet,
physical activity, cognitive measures (attitudes, beliefs, and self-efficacy), social
support, and environmental measures.

Inclusion Criteria


- Self-identified as Black or African-American

- Body mass index ≥ 30 kg/m²


- Pre- or perimenopausal

- Not pregnant or nursing

- Not planning to become pregnant

- Not planning to move from the Chicago area during the active and maintenance study
interventions (18 months)

- No exercise intolerance due to chronic obstructive pulmonary disease (e.g.,
emphysema, chronic bronchitis, or exercise-induced asthma)

- No cancer requiring treatment within the past 5 years, except nonmelanoma skin cancer

- No diabetes

- No uncontrolled hypertension

- Participants on hypertensive medication may be eligible upon approval by the

- None of the following conditions:

- Unstable angina

- Orthostatic hypotension

- Moderate to severe aortic stenosis

- Uncontrolled arrhythmia

- Uncontrolled congestive heart failure

- Pulmonary embolism within the past 6 months

- History of cardiac arrest

- No significant mental illness (e.g., schizophrenia or unmedicated bipolar disorder)

- No alcohol intake of > 2 drinks per day

- No illegal drug use

- No laxative abuse (i.e., > twice the recommended dose)


- No concurrent treatment for an eating disorder

- No concurrent medications (e.g., hormone-replacement therapy) that could interfere
with adherence to an exercise program or could interfere with study outcomes

- No concurrent participation in a formal weight-loss program

- No concurrent pharmacotherapy for weight loss

Type of Study:


Study Design:

Allocation: Randomized

Outcome Measure:

Body mass index as assessed at baseline, 24 weeks, and 18 months

Safety Issue:


Principal Investigator

Marian Fitzgibbon, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Illinois


United States: Federal Government

Study ID:




Start Date:

July 2004

Completion Date:

Related Keywords:

  • Breast Cancer
  • Obesity
  • Weight Changes
  • breast cancer
  • weight changes
  • obesity
  • Body Weight Changes
  • Breast Neoplasms
  • Obesity



University of Illinois Cancer Center Chicago, Illinois  60612-7243